by Clinical Neuropsychologist Online | Thursday, March 28, 2024 | Dementia
Abstract INTRODUCTION Published norms are typically cross-sectional and often are not sensitive to preclinical cognitive changes due to dementia. We developed and validated demographically adjusted cross-sectional and longitudinal normative standards using harmonized...
by Clinical Neuropsychologist Online | Thursday, March 28, 2024 | Dementia
Abstract INTRODUCTION Lewy body disease (LBD) is a common primary or co-pathology in neurodegenerative syndromes. An alpha-synuclein seed amplification assay (αSyn-SAA) is clinically available, but clinical performance, especially lower sensitivity in...
by Clinical Neuropsychologist Online | Wednesday, March 27, 2024 | Dementia
Abstract INTRODUCTION Fatty acids (FAs) are the building blocks of complex lipids and signaling compounds; the role of the lipidome fatty acid profile (LFA) in AD progression remains unclear. METHODS The LFA of plasma and cerebrospinal fluid (CSF) samples from 289...
by Clinical Neuropsychologist Online | Wednesday, March 27, 2024 | Dementia
Abstract Despite numerous studies in the field of dementia and Alzheimer’s disease (AD), a comprehensive understanding of this devastating disease remains elusive. Bulk transcriptomics have provided insights into the underlying genetic factors at a high level....
by Clinical Neuropsychologist Online | Wednesday, March 27, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | March 27, 2024 Wiley: Alzheimer’s & Dementia: Table...
